Pfizer and BioNTech Have Begun Submitting Data to U.S. Regulators to Seek Emergency Use ... - Latest Tweet by Reuters

Pfizer and BioNTech have begun submitting data to U.S. regulators to seek emergency use authorization of their COVID-19 vaccine for children under the age of 5, despite weaker-than-expected immune responses in their clinical trial of 2- to 4-year-olds https://t.co/S4sQN6vcR0 pic.twitter.com/XZLe6VBzF1— Reuters (@Reuters) February 2, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)